{"id":"https://genegraph.clinicalgenome.org/r/3a957fa0-f63b-4d1a-a25b-a2b09958abaev1.0","type":"EvidenceStrengthAssertion","dc:description":"*SLC24A1* was first reported in relation to autosomal recessive congenital stationary night blindness (CSNB) in 2010 (Riazuddin et al., PMID: 20850105). Patients with CSNB mainly experience night blindness, however depending upon the clinical classification of CSNB, other ocular features including reduced visual acuity, photophobia, myopia, nystagmus, and strabismus have also been reported (PMID: 26822852). Disease-causing variants in *SLC24A1* have been implicated in autosomal recessive retinitis pigmentosa as well (PMIDs: 27624628, 35486108, 36729443). Despite variability in phenotypic features, the cases share overlapping phenotypes consistent with a single spectrum of disease. No differences in inheritance patterns or disease mechanisms were observed. Therefore, per criteria outlined by the ClinGen Lumping & Splitting Working Group, cases of congenital stationary night blindness (complete) 1D (MIM#: 613830) or retinitis pigmentosa caused by biallelic *SLC24A1* variants have been lumped together into a single disease entity referred to as SLC24A1-related retinopathy.\n\nSeven variants (including, missense, in-frame indel, nonsense, and frameshift) that have been reported in seven probands in four publications (PMIDs: 20850105, 26822852, 35486108, and 35446361) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function.\n\nThis gene-disease relationship is also supported by experimental evidence including a mouse model (PMID: 26246500) and expression studies (PMID: 20850105). In mice, the expression of *Slc24a1* was detected in the retina around postnatal day 7. *In-situ* hybridization and immunohistological studies localized *Slc24a1* to the inner segment, outer and inner nuclear layers, and ganglion cells of the mouse retina (PMID: 20850105). A mouse model in which *Slc24a1* was deleted showed abnormally formed outer segment disks, suppressed expression, and function of rod CNG channels, which resulted in a 100-fold reduction in rod responses, whereas cone responses were normal (PMID: 26246500, 35446361).\n\nIn summary, there is definitive evidence supporting the relationship between *SLC24A1* and autosomal recessive SLC24A1-related retinopathy. This has been repeatedly demonstrated in research and clinical diagnostic settings and upheld over time without the emergence of contradictory evidence. This classification was approved by the ClinGen Retina GCEP on the meeting date September 5th, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3a957fa0-f63b-4d1a-a25b-a2b09958abae","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3071ba1a-21c2-46a7-a5e9-bc53c015c7a9","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3071ba1a-21c2-46a7-a5e9-bc53c015c7a9_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2024-09-05T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/3071ba1a-21c2-46a7-a5e9-bc53c015c7a9_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2024-10-01T01:21:07.316Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3071ba1a-21c2-46a7-a5e9-bc53c015c7a9_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3071ba1a-21c2-46a7-a5e9-bc53c015c7a9_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/07b9a087-ad92-414d-9598-1f9540f8d373","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44dda40b-06cb-4c0e-95b4-76897353cfcd","type":"Finding","dc:description":"The mouse model shows a 100-fold reduction in rod responses while preserving cone responses. This is classic for CSNB.  ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26246500","rdfs:label":"Mouse model for CSNB with mutant Slc24a1","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3071ba1a-21c2-46a7-a5e9-bc53c015c7a9_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48296a0d-90a1-4ac7-9d19-d55a80c151e9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a0ae157-83ea-4255-b371-24ef2c0ffeb3","type":"Finding","dc:description":"Slc24a1 expression was detected using the commercially available anti-SLC24A1 antibody in mouse retinal inner segment, the outer and inner nuclear layers, and ganglion cells in both p13 and adult mouse eyes. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20850105","rdfs:label":" Immunolocalization of Slc24a1 expression mouse retina","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/3071ba1a-21c2-46a7-a5e9-bc53c015c7a9_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66094470-6e2c-4c4c-8509-676ca69abdcb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cdd6d546-6489-42bf-9fea-5dc3c4c08b1f","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cdd6d546-6489-42bf-9fea-5dc3c4c08b1f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35486108","allele":{"id":"https://genegraph.clinicalgenome.org/r/aad2dfa0-1e01-45de-acc2-bb3d4e48823c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004727.3(SLC24A1):c.95T>A (p.Leu32Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA392912392"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/66094470-6e2c-4c4c-8509-676ca69abdcb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35486108","rdfs:label":"Millo_MOL0983-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":44,"allele":{"id":"https://genegraph.clinicalgenome.org/r/aad2dfa0-1e01-45de-acc2-bb3d4e48823c"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Late-onset RP at 44 years, ffERG nondetectable, with very reduced residual cone responses. Visual field 10-15 degrees of fixation using the V target. ","phenotypes":"obo:HP_0001123","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cdd6d546-6489-42bf-9fea-5dc3c4c08b1f_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/5e5874d6-1cce-4e54-ae44-8876c3d9012d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92614740-a52f-44ec-b39f-60b390fad609","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92614740-a52f-44ec-b39f-60b390fad609_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20850105","allele":{"id":"https://genegraph.clinicalgenome.org/r/864e1418-558b-4a41-87f1-9d712e0971bc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004727.3(SLC24A1):c.1613_1614del (p.Phe538CysfsTer23)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7619941"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/5e5874d6-1cce-4e54-ae44-8876c3d9012d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20850105","rdfs:label":"Riazuddin_PKRP070_14","allele":{"id":"https://genegraph.clinicalgenome.org/r/864e1418-558b-4a41-87f1-9d712e0971bc"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Night blindness since early childhood. ","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/92614740-a52f-44ec-b39f-60b390fad609_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/bf308d96-70a3-4d72-bb99-df0f85b35470_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/183ee05b-e162-4e4b-a1be-5b885feacc0b","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/183ee05b-e162-4e4b-a1be-5b885feacc0b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35446361","allele":{"id":"https://genegraph.clinicalgenome.org/r/2f4aa0c4-8817-49de-9c82-06de0ed11e0a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004727.3(SLC24A1):c.823_824del (p.Val275HisfsTer15)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139664035"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/bf308d96-70a3-4d72-bb99-df0f85b35470","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35446361","rdfs:label":"Marques_1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":42,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2f4aa0c4-8817-49de-9c82-06de0ed11e0a"},"detectionMethod":"The paper mentioned \"genetic testing\" without providing any details on the methods. ","phenotypeFreeText":"nyctalopia, atrophic and perivascular changes on the fundus, RPE atrophy, bone spicules hyperpigmentation, Riggs type ERG","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/183ee05b-e162-4e4b-a1be-5b885feacc0b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/4a998992-b57a-4e02-bf99-fb242bfa8321_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b707fb6-b4ed-41e6-8068-48c28a90db9d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b707fb6-b4ed-41e6-8068-48c28a90db9d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26822852","allele":{"id":"https://genegraph.clinicalgenome.org/r/99df7f27-cf16-4cc6-a58b-41c07b2612ff","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004727.3(SLC24A1):c.1691_1693del (p.Phe564del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA618958027"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/dd77c02a-f61b-425b-a8fd-e02c73ca758a","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd77c02a-f61b-425b-a8fd-e02c73ca758a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26822852","allele":{"id":"https://genegraph.clinicalgenome.org/r/fb441476-3b6e-4ca3-a269-7b1d24f4b40f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004727.3(SLC24A1):c.3291_3294del (p.Val1099GlufsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7620344"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4a998992-b57a-4e02-bf99-fb242bfa8321","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26822852","rdfs:label":"Neuille_Family2_I","allele":[{"id":"https://genegraph.clinicalgenome.org/r/99df7f27-cf16-4cc6-a58b-41c07b2612ff"},{"id":"https://genegraph.clinicalgenome.org/r/fb441476-3b6e-4ca3-a269-7b1d24f4b40f"}],"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Unclassified CSNB, night blindness since early childhood. ","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5b707fb6-b4ed-41e6-8068-48c28a90db9d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/dd77c02a-f61b-425b-a8fd-e02c73ca758a_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/630210ca-d5d8-45d2-bd45-92e1c33eec49_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f76a39c3-d756-46e8-9115-82f384e01589","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f76a39c3-d756-46e8-9115-82f384e01589_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35486108","allele":{"id":"https://genegraph.clinicalgenome.org/r/aad2dfa0-1e01-45de-acc2-bb3d4e48823c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/630210ca-d5d8-45d2-bd45-92e1c33eec49","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35486108","rdfs:label":"Millo_MOL1637-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":52,"allele":{"id":"https://genegraph.clinicalgenome.org/r/aad2dfa0-1e01-45de-acc2-bb3d4e48823c"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Iraqi-Jewish - Nyctalopia in late teens. Legally blind at 35 years. \nAt 52, advanced RP, optic disk pallor, vascular attenuation, and pigmentary changes in the peripheral retina. ","phenotypes":["obo:HP_0007688","obo:HP_0000662","obo:HP_0000510"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f76a39c3-d756-46e8-9115-82f384e01589_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/3071ba1a-21c2-46a7-a5e9-bc53c015c7a9_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d56deee-bc77-4334-a3d4-56b8cf3aa2c8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35486108","rdfs:label":"Millo_MOL1637-1","family":{"id":"https://genegraph.clinicalgenome.org/r/2d56deee-bc77-4334-a3d4-56b8cf3aa2c8","type":"Family","rdfs:label":"Millo_MOL1637-1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/630210ca-d5d8-45d2-bd45-92e1c33eec49"}},"phenotypeFreeText":"Iraqi-Jewish - Nyctalopia in late teens. Legally blind at 35 years. \nAt 52, advanced RP, optic disk pallor, vascular attenuation, and pigmentary changes in the peripheral retina. ","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000662","obo:HP_0000510","obo:HP_0007688"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/630210ca-d5d8-45d2-bd45-92e1c33eec49"}},{"id":"https://genegraph.clinicalgenome.org/r/f5076454-a28a-4483-b595-610dc0686b12_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26822852","rdfs:label":"Neuille_Family2","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/f5076454-a28a-4483-b595-610dc0686b12","type":"Family","rdfs:label":"Neuille_Family2","member":{"id":"https://genegraph.clinicalgenome.org/r/4a998992-b57a-4e02-bf99-fb242bfa8321"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Unclassified CSNB, night blindness since early childhood. ","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/4a998992-b57a-4e02-bf99-fb242bfa8321"}},{"id":"https://genegraph.clinicalgenome.org/r/93dfc883-3819-47f3-978e-2da65d39f3d4_proband_segregation","type":"FamilyCosegregation","dc:description":"SLC24A1 was considered a good candidate because of its expression and function in the rod outer segments. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20850105","rdfs:label":"Riazuddin_PKRP070","estimatedLodScore":4.91,"family":{"id":"https://genegraph.clinicalgenome.org/r/93dfc883-3819-47f3-978e-2da65d39f3d4","type":"Family","rdfs:label":"Riazuddin_PKRP070","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/5e5874d6-1cce-4e54-ae44-8876c3d9012d"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Riggs type ERG. Normal fundus examination","phenotypeNegativeAlleleNegative":20,"phenotypePositiveAllelePositive":5,"proband":{"id":"https://genegraph.clinicalgenome.org/r/5e5874d6-1cce-4e54-ae44-8876c3d9012d"},"publishedLodScore":5.9,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/64ca80af-b434-46bd-92d1-c5b10262cefe_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35486108","rdfs:label":"Millo_MOL0983-1","family":{"id":"https://genegraph.clinicalgenome.org/r/64ca80af-b434-46bd-92d1-c5b10262cefe","type":"Family","rdfs:label":"Millo_MOL0983-1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/66094470-6e2c-4c4c-8509-676ca69abdcb"}},"phenotypeFreeText":"Late-onset RP at 44 years, ffERG nondetectable, with very reduced residual cone responses. Visual field 10-15 degrees of fixation using the V target. ","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0001123","proband":{"id":"https://genegraph.clinicalgenome.org/r/66094470-6e2c-4c4c-8509-676ca69abdcb"}},{"id":"https://genegraph.clinicalgenome.org/r/c9d70a9c-beac-4987-9f3d-deb4dc52f407_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26822852","rdfs:label":"Neuille_Family3","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/c9d70a9c-beac-4987-9f3d-deb4dc52f407","type":"Family","rdfs:label":"Neuille_Family3","member":{"id":"https://genegraph.clinicalgenome.org/r/8efc2cec-6cf9-4919-bc5a-544dcae85cdd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26822852","rdfs:label":"Neuille_Family3_I","ageType":"AgeAtReport","ageUnit":"Years","ageValue":36,"allele":{"id":"https://genegraph.clinicalgenome.org/r/83085fd3-ad57-4cc0-acbe-55e5715d9474","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004727.3(SLC24A1):c.2968A>C (p.Ser990Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA392902212"}},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Unclassified CSNB. Scotopic ERG severely reduced for a and b waves, and photopic ERG was normal. ","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1850d46e-ec52-4f40-ad12-072270261004_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26822852","allele":{"id":"https://genegraph.clinicalgenome.org/r/83085fd3-ad57-4cc0-acbe-55e5715d9474"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Unclassified CSNB. Scotopic ERG severely reduced for a and b waves, and photopic ERG was normal. ","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/8efc2cec-6cf9-4919-bc5a-544dcae85cdd"}},{"id":"https://genegraph.clinicalgenome.org/r/d273d399-2dc8-4e17-a91d-4f74a5b9d5ea_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26822852","rdfs:label":"Neuille_Family1","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/d273d399-2dc8-4e17-a91d-4f74a5b9d5ea","type":"Family","rdfs:label":"Neuille_Family1","member":{"id":"https://genegraph.clinicalgenome.org/r/e3bf4056-57a9-4be3-b211-8c74d1d17490","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26822852","rdfs:label":"Neuille_Family1_I","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e98e0fae-d0b8-49de-be14-4fe156362d45","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004727.3(SLC24A1):c.2401G>T (p.Glu801Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA392899198"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Severely reduced scotopic ERG for a and b waves. Photopic ERG was normal.","phenotypes":"obo:HP_0030641","previousTesting":true,"previousTestingDescription":"Sanger sequencing of known genes CACNA1F, CACNA2D4, CABP4, CACN2B was negative\n","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/13c949ee-d3b8-4dd0-a62b-7f12d03e8873_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26822852","allele":{"id":"https://genegraph.clinicalgenome.org/r/e98e0fae-d0b8-49de-be14-4fe156362d45"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Severely reduced scotopic ERG for a and b waves. Photopic ERG was normal.","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0030641","proband":{"id":"https://genegraph.clinicalgenome.org/r/e3bf4056-57a9-4be3-b211-8c74d1d17490"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e3bf4056-57a9-4be3-b211-8c74d1d17490_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13c949ee-d3b8-4dd0-a62b-7f12d03e8873","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13c949ee-d3b8-4dd0-a62b-7f12d03e8873_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/e3bf4056-57a9-4be3-b211-8c74d1d17490"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/8efc2cec-6cf9-4919-bc5a-544dcae85cdd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1850d46e-ec52-4f40-ad12-072270261004","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1850d46e-ec52-4f40-ad12-072270261004_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/8efc2cec-6cf9-4919-bc5a-544dcae85cdd"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":9101,"specifiedBy":"GeneValidityCriteria10","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Qy2x6V15Rzo","type":"GeneValidityProposition","disease":"obo:MONDO_0019118","gene":"hgnc:10975","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3071ba1a-21c2-46a7-a5e9-bc53c015c7a9-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}